Lattice Biologics Ltd V.LBL.H

Alternate Symbol(s): LBLTF

Healthcare Biotechnology

Lattice Biologics Ltd. is engaged in the business of developing, manufacturing and marketing biologics products to domestic and international markets. The Company’s products are used in a variety of applications including enhancing bone regeneration in dental, spine, and general orthopedic indications. Its acellular dermal matrix is used for dental flaps which is used to close defects post-implantation. The Company’s stem cell-based technology AmnioBoost, is an amniotic fluid concentrate, which can be used to accelerate and enhance bone regeneration for dental post implantation. In addition, its products complimentary to the dental allograft market are amniotic membrane, Demineralized bone matrix (DBM) putty, acellular dermal matrix and cancellous DBM sponges.

TSXV:LBL.H - Post by User

Lattice Biologics Ltd > Core vs. COVID19

<< Previous

Bullboard Posts

Next >>

Comment by GekkoInvestor19on Jul 20, 2020 7:09pm

101 Views

Post# 31293185

RE:RE:RE:RE:RE:RE:RE:RE:RE:Core vs. COVID19

My only issue with Guy is his lack of correspondence with his Shareholders. Some would argue that he may not have anything to say, and that may be the case, but at least tell us that.

Its frustrating when you invest thousands of dollars into a company, and when you contact the head of said company, you get zero response.

At least acknowledge that you received the emails from your shareholders. At this point I feel as though I could have a more riveting conversation with a shoe.

All that said, I remain optimistic.... end rant.

<< Previous

Bullboard Posts

Next >>

5 steps to mastering risk management in the stock market